Analysts ponder whether activist fund Elliott is more in need of a ‘shake-up’ than the firms it invests in

Activist investor Elliott has ramped up its pressure on UK businesses this year, taking on builder Taylor Wimpey, pharmaceuticals firm Glaxo Smith Kline, and energy giant SSE. It took a sizeable top-five stake in SSE in September and last week wrote a ten-page letter to the firm’s chairman Sir John Manzoni criticising the firm’s CEO [...]